Korean Journal of Psychosomatic Medicine (정신신체의학)

Korean Psychosomatic Society (한국정신신체의학회)
권호 표지
DOI QR코드

DOI QR Code

Association between Cognitive function, Behavioral and Psychological Symptoms of Dementia and Temporal Lobe Atrophy in Patients with Alzheimer's Disease and Mild Cognitive Impairment

알츠하이머형 치매 및 경도인지장애 환자에서 인지기능 및 행동심리증상과 내측두엽 위축의 연관성

  • Jeong, Jae Yoon (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Lee, Kang Joon (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Hyun (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
  • 정재윤 (인제대학교 의과대학 일산백병원 정신건강의학교실) ;
  • 이강준 (인제대학교 의과대학 일산백병원 정신건강의학교실) ;
  • 김현 (인제대학교 의과대학 일산백병원 정신건강의학교실)
  • Received : 2019.09.16
  • Accepted : 2019.11.19
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The aim of this study was to compare severity, neurocognitive functions, and behavioral and psychological symptoms of dementia (BPSD) according to the degree of temporal lobe atrophy (MTA) in Korean patients with dementia due to Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease. Methods : Participants were 114 elderly subjects diagnosed with Alzheimer's disease or mild cognitive impairment in this cross-sectional study. MTA in brain MRI was rated with standardized visual rating scales (Scheltens scale) and the subjects were divided into two groups according to Scheltens scale. Severity was evaluated with Clinical Dementia Rating (CDR) and Global Deterioration Scale (GDS). Neurocognitive functions was evaluated with the Korean version of Short Blessed Test (SBT-K) and the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease assessment packet (CERAD-K). BPSD was evaluated with the Korean version of the Neuropsychiatric Inventory (K-NPI). Independent t-test was performed to compare severity, neurocognitive functions, and BPSD between two groups. Results : The group with high severity of MTA showed significantly lower scores in CDR, SBT-K, MMSE-KC, modified Boston naming test, word list recognition, and word list memory (p<0.05). There were no differences in K-NPI scores between two groups. Conclusions : Severity and neurocognitive functions of dementia had significant positive association with MTA, but BPSD had no association with MTA. Evaluating MTA seems to have potential benefit in diagnosing and treating neurocognitive impairments in the elderly. Further evaluation is needed to confirm the association between certain brain structures and BPSD.

연구목적 본 연구의 목적은 알츠하이머형 치매 및 경도인지장애 환자에서 내측두엽 위축 정도의 차이에 따른 중증도, 신경인지기능 및 행동심리증상을 비교하는 것이다. 방 법 본 연구는 단면 연구로서, 알츠하이머형 치매 및 경도인지장애로 진단받은 114명을 대상으로 하였다. 내측두엽 위축은 표준화된 시각 기반 척도(Scheltens scales)에 의해 평가되었으며, 대상군은 두 그룹으로 분류되었다. 중증도는 임상치매평가척도(Clinical dementia rating, CDR)와 전반적 퇴화 척도(Global deterioration scale, GDS)로 평가되었으며 신경인지기능은 한국어판 간이 블레스드 검사(The Korean version of the short blessed test, SBT-K), 한국형 CERAD (The Korean version of the consortium to establish a registry for Alzheimer's disease, CERAD-K), 행동심리증상은 한국형 신경정신행동검사(The Korean version of the Neuropsychiatric Inventory, K-NPI)로 평가되었다. 내측두엽 위축의 정도에 따른 중증도와 신경인지기능 및 행동심리증상의 차이를 분석하기 위해 독립표본 t-test를 시행하였다. 결 과 내측두엽 위축의 중증도가 높은 군은 낮은 군에 비하여 CDR, SBT-K, 그리고 CERAD-K의 하부항목 중 네가지 항목에서 유의하게 낮은 점수를 보였다(p<0.05). 결 론 내측두엽 위축과 중증도 및 신경인지기능 사이에는 유의한 양의 상관관계가 나타났으나 행동심리증상과는 유의한 상관관계가 나타나지 않았다. 내측두엽 위축의 평가는 인지장애의 진단과 치료에 잠재적 이점을 제공할 것으로 생각된다. 행동심리증상과 뇌구조의 연관성에 대해서는 추가적인 연구가 필요할 것으로 보인다.

Keywords

References

  1. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. Jama 2002;288:1475-1483. https://doi.org/10.1001/jama.288.12.1475
  2. Piccininni M, Di Carlo A, Baldereschi M, Zaccara G, Inzitari D. Behavioral and psychological symptoms in Alzheimer's disease: Frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord 2005;19:276-281. https://doi.org/10.1159/000084552
  3. Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 11th ed. Philadelphia: Wolters Kluwer;2016. p.704-740.
  4. Yilmaz R, Pilotto A, Roeben B, Preische O, Suenkel U, Heinzel S, Metzger FG, Laske C, Maetzler W, Berg D. Structural Ultrasound of the Medial Temporal Lobe in Alzheimer's Disease. Ultraschall Med 2017;38:294-300. https://doi.org/10.1055/s-0042-107150
  5. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259. https://doi.org/10.1007/BF00308809
  6. Overdorp EJ, Kessels RP, Claassen JA, Oosterman JM. Cognitive impairments associated with medial temporal atrophy and white matter hyperintensities: an MRI study in memory clinic patients. Front Aging Neurosci 2014;6:98.
  7. Jonker C, Launer LJ, Hooijer C, Lindeboom J. Memory complaints and memory impairment in older individuals. J Am Geriatr Soc 1996;44:44-49. https://doi.org/10.1111/j.1532-5415.1996.tb05636.x
  8. Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, Schapiro MB. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 1998;43:60-68. https://doi.org/10.1016/S0006-3223(97)00013-9
  9. Squire LR, Stark CE, Clark RE. The medial temporal lobe. Annu Rev Neurosci 2004;27:279-306. https://doi.org/10.1146/annurev.neuro.27.070203.144130
  10. Burns A, Jacoby R, Levy R. Psychiatric phenomena in alzheimer's disease. Iv: Disorders of behaviour. Br J Psychiatry 1990;157:86-94. https://doi.org/10.1192/bjp.157.1.86
  11. Garcia-Alberca JM, Florido M, Caceres M, Sanchez-Toro A, Lara JP, Garcia-Casares N. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease. Psychogeriatrics 2019;19:46-54. https://doi.org/10.1111/psyg.12363
  12. Staekenborg SS, Gillissen F, Romkes R, Pijnenburg YA, Barkhof F, Scheltens P, van der Flier WM. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease. Int J Geriatr Psychiatry 2008;23:387-392. https://doi.org/10.1002/gps.1891
  13. Hsu JL, Lee WJ, Liao YC, Lirng JF, Wang SJ, Fuh JL. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment. PLoS One 2015;10:e0137121. https://doi.org/10.1371/journal.pone.0137121
  14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the Nincds-Adrda Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944. https://doi.org/10.1212/WNL.34.7.939
  15. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246. https://doi.org/10.1111/j.1365-2796.2004.01380.x
  16. Claus JJ, Staekenborg SS, Holl DC, Roorda JJ, Schuur J, Koster P, Tielkes CEM, Scheltens P. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population. Eur Radiol 2017;27:3147-3155. https://doi.org/10.1007/s00330-016-4726-3
  17. Ferreira D, Cavallin L, Larsson EM, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; Add-NeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in alzheimer's disease and mild cognitive impairment. J Intern Med 2015;278:277-290. https://doi.org/10.1111/joim.12358
  18. Velickaite V, Ferreira D, Cavallin L, Lind L, Ahlstrom H, Kilander L, Westman E, Larsson EM. Medial temporal lobe atrophy ratings in a large 75-year-old population-based cohort: gender-corrected and education-corrected normative data. Eur Radiol 2018;28:1739-1747. https://doi.org/10.1007/s00330-017-5103-6
  19. Choi L, Joo SH, Lee CU, Paik IH. Association between Global Cortical Atrophy, Medial Temporal Atrophy, White Matter Hyperintensities and Cognitive Functions in Korean Alzheimer's Disease Patients. Korean J Biol Psychiatry 2015;22:140-148.
  20. Morris JC. The Clinical Dementia Rating (Cdr): current version and scoring rules. Neurology 1993;43:2412-2414. https://doi.org/10.1212/WNL.43.1_Part_1.241-a
  21. Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale (Gds). Psychopharmacol Bull 1988;24:661-663.
  22. Fillenbaum GG, Heyman A, Wilkinson WE, Haynes CS. Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test. Arch Neurol 1987;44:924-927. https://doi.org/10.1001/archneur.1987.00520210026014
  23. Lee DY, Yoon JC, Lee KU, Jhoo JH, Kim KW, Lee JH, Woo JI. Reliability and Validity of the Korean Version of Short Blessed Test(Sbt-K) as a Dementia Screening Instrument. J Korean Neuropsychiatr Assoc 1999;38:1365-1375.
  24. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, Lee KH, Kim SY, Han SH, Woo JI. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (Cerad-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:47-53. https://doi.org/10.1093/geronb/57.1.P47
  25. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314. https://doi.org/10.1212/WNL.44.12.2308
  26. Persson K, Barca ML, Cavallin L, Brækhus A, Knapskog AB, Selbaek G, Engedal K. Comparison of automated volumetry of the hippocampus using $Neuroquant^{(R)}$ and visual assessment of the medial temporal lobe in Alzheimer's disease. Acta Radiol 2018;59:997-1001. https://doi.org/10.1177/0284185117743778
  27. Ten Kate M, Barkhof F, Boccardi M, Visser PJ, Jack CR Jr, Lovblad KO, Frisoni GB, Scheltens P; Geneva Task Force for the Roadmap of Alzheimer's Biomarkers. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiol Aging 2017;52:167-182. https://doi.org/10.1016/j.neurobiolaging.2016.05.024
  28. Harper L, Barkhof F, Fox NC, Schott JM. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 2015;86:1225-1233. https://doi.org/10.1136/jnnp-2014-310090
  29. Dhikav V, Sethi M, Anand KS. Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression. Br J Radiol 2014;87:20140150. https://doi.org/10.1259/bjr.20140150
  30. Persson K, Barca ML, Eldholm RS, Cavallin L, Saltyte Benth J, Selbæk G, Brækhus A, Saltvedt I, Engedal K. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease. Dement Geriatr Cogn Disord 2017;44:12-24. https://doi.org/10.1159/000477342
  31. Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012;135:1860-1870. https://doi.org/10.1093/brain/aws093
  32. Matthews BR. Memory dysfunction. Continuum (Minneap Minn) 2015;21:613-626.
  33. Laakso MP, Soininen H, Partanen K, Helkala EL, Hartikainen P, Vainio P, Hallikainen M, Hänninen T, Riekkinen PJ Sr. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect 1995;9:73-86. https://doi.org/10.1007/BF02252964
  34. Stout JC, Bondi MW, Jernigan TL, Archibald SL, Delis DC, Salmon DP. Regional cerebral volume loss associated with verbal learning and memory in dementia of the Alzheimer type. Neuropsychology 1999;13:188-197. https://doi.org/10.1037/0894-4105.13.2.188
  35. Beck IR, Gagneux-Zurbriggen A, Berres M, Taylor KI, Monsch AU. Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (Cerad-Nab) versus California Verbal Learning Test (CVLT). Arch Clin Neuropsychol 2012 27:510-519. https://doi.org/10.1093/arclin/acs056
  36. Dos Santos V, Thomann PA, Wustenberg T, Seidl U, Essig M, Schroder J. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011;23:411-420. https://doi.org/10.3233/JAD-2010-100156
  37. Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry 2002;47:723-733. https://doi.org/10.1177/070674370204700803
  38. Kandiah N, Chander R, Zhang A, Yee CC. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease. J Neurol Sci 2014;337:162-166. https://doi.org/10.1016/j.jns.2013.11.042
  39. Palmqvist S, Sarwari A, Wattmo C, Bronge L, Zhang Y, Wahlund LO, Nagga K. Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2011;32:417-423. https://doi.org/10.1159/000335778
  40. Ogama N, Sakurai T, Saji N, Nakai T, Niida S, Toba K, Umegaki H, Kuzuya M. Frontal White Matter Hyperintensity Is Associated with Verbal Aggressiveness in Elderly Women with Alzheimer Disease and Amnestic Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra 2018;8:138-150. https://doi.org/10.1159/000486826
  41. Kang DW, Lim HK. Current Knowledge and Clinical Application of Brain Imaging in Alzheimer's Disease. J Korean Neuropsychiatr Assoc 2018;57:12-22. https://doi.org/10.4306/jknpa.2018.57.1.12